This change frees researchers to study cannabis products that most consumers encounter when buying medical marijuana – which could accelerate its treatment potential.
Articles on Schedule III drugs
Displaying all articles
The proposed rescheduling of marijuana could have far-reaching implications in science, medicine and criminal justice. What is the best policy option?
Moving marijuana to a less restrictive category under the Controlled Substances Act poses benefits and potential risks. But no effective medicine is free from risks.
